Last update 01 Nov 2024

IL-10 x GAD2 x GDNF family

Basic Info

Related Targets
IL-10GAD2GDNF family

Related

1
Drugs associated with IL-10 x GAD2 x GDNF family
KLS-2031
Target
GAD2 x GDNF family x IL-10
Mechanism
GAD2 modulators [+2]
Active Org.
KOLON LIFE SCIENCE, Inc.KOLON LIFE SCIENCE, Inc.
Originator Org.
KOLON LIFE SCIENCE, Inc.KOLON LIFE SCIENCE, Inc.
Active Indication
Sciatica [+1]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
2
Clinical Trials associated with IL-10 x GAD2 x GDNF family
NCT05613569 / Active, not recruitingNot Applicable
A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study
NCT04238793 / CompletedPhase 1/2
A Phase 1/2a, First-in-Human, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Therapeutic Activity of Single Ascending Doses of KLS-2031 Administered by Transforaminal Epidural Injection in Patients With Neuropathic Pain From Lumbosacral Radiculopathy
100 Clinical Results associated with IL-10 x GAD2 x GDNF family
Login to view more data
100 Translational Medicine associated with IL-10 x GAD2 x GDNF family
Login to view more data
0 Patents (Medical) associated with IL-10 x GAD2 x GDNF family
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free